Dr. Tuazon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 Fairview Ave. N
Seattle, WA 98109
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2018
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2009 - 2012
University of Santo TomasClass of 2006
Certifications & Licensure
WA State Medical License 2016 - 2026
PA State Medical License 2009 - 2016
VA State Medical License 2014 - 2016
Awards, Honors, & Recognition
- Magna cum laude University of Santo Tomas Faculty of Medicine and Surgery, 2006
Publications & Presentations
PubMed
- 2 citationsAcquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma.Andrew J Portuguese, Min Fang, Sherilyn A Tuazon, Margot Pont, Xiaoyu Qu
Blood Advances. 2023-12-12 - 45 citationsLisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.Tanya Siddiqi, David G Maloney, Saad S Kenderian, Danielle M Brander, Kathleen Dorritie
Lancet. 2023-08-19 - 27 citationsγ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, ...Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till
The Lancet. Oncology. 2023-07-01
Abstracts/Posters
- Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...Sherilyn A. Tuazon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Prolonged Lenalidomide Therapy in Multiple Myeloma Patients Does Not Impact Autologous PBSC Mobilization: A Single Center Retrospective Analysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Associate
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- European Society for Medical OncologyMember
Other Languages
- Filipino
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
